Cell Therapy for IBM by Muscle Injection of ADSVF

Clinical trial NCT05032131 · UNKNOWN

Trial details

NCT number: NCT05032131
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Inclusion Body Myositis

Start date: 2023-02-01
Primary completion: 2023-10-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.